Fifth Third Wealth Advisors LLC Boosts Position in Zoetis Inc. $ZTS

Fifth Third Wealth Advisors LLC lifted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 9.4% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 9,323 shares of the company’s stock after acquiring an additional 802 shares during the period. Fifth Third Wealth Advisors LLC’s holdings in Zoetis were worth $1,454,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. Nova Wealth Management Inc. purchased a new position in shares of Zoetis during the 1st quarter worth $25,000. 1248 Management LLC purchased a new position in shares of Zoetis during the 1st quarter worth $27,000. Saudi Central Bank acquired a new stake in shares of Zoetis during the 1st quarter worth about $29,000. REAP Financial Group LLC increased its position in shares of Zoetis by 201.5% during the 2nd quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock worth $31,000 after purchasing an additional 131 shares during the last quarter. Finally, Cornerstone Planning Group LLC increased its position in shares of Zoetis by 79.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 199 shares of the company’s stock worth $30,000 after purchasing an additional 88 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

ZTS has been the subject of a number of recent analyst reports. Leerink Partners downgraded Zoetis from an “outperform” rating to a “market perform” rating and cut their price objective for the stock from $180.00 to $155.00 in a research report on Thursday, July 17th. Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a research report on Wednesday. Leerink Partnrs downgraded Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Stifel Nicolaus downgraded Zoetis from a “buy” rating to a “hold” rating and cut their price objective for the stock from $165.00 to $160.00 in a research report on Wednesday, June 18th. Finally, Piper Sandler raised their price objective on Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Monday, August 11th. Four investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, Zoetis has an average rating of “Hold” and an average price target of $196.71.

Zoetis Stock Performance

NYSE ZTS opened at $141.05 on Friday. The company has a market cap of $62.51 billion, a P/E ratio of 24.28, a P/E/G ratio of 2.26 and a beta of 0.90. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. The stock has a 50-day moving average of $149.24 and a two-hundred day moving average of $154.41. Zoetis Inc. has a 1-year low of $139.34 and a 1-year high of $196.55.

Zoetis (NYSE:ZTS) last released its earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.14. The company had revenue of $2.46 billion during the quarter, compared to the consensus estimate of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.Zoetis’s revenue was up 4.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. Zoetis’s payout ratio is currently 34.42%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.